Researchers reported a cost-effective HPLC workflow that separates both epimers of the antibiotic prodrug cefpodoxime proxetil in human plasma while characterizing its active metabolite and quantifying rapid hydrolysis. The method is designed for integrated pharmacokinetic and bioanalysis use cases, supporting more efficient characterization of prodrug activation in development and study settings.